Sydney startups selected for program
Australia’s science agency CSIRO has announced the 12 planned deep-tech startups selected for its 2024 ON Accelerate program.
There were two successful University of Sydney teams:
- Environmental Measurement Unit Systems or EMUS, from the Faculty of Medicine and Health deliver advanced heat stress management systems for athletes that optimise performance in real time and keep players safe.
- Plasmid Therapy is a joint effort from The Westmead Institute for Medical Research and The University of Sydney. The team is working on a technology that addresses the global threat of antimicrobial-resistant (AMR) infections. Removing AMR genes from bacteria and keeping them out with an affordable and safe oral solution makes common treatments safer and more effective.
On Accelerate allows research teams to validate and develop innovative ventures offering high potential. Concepts supported by the program range from global health challenges to sustainability through circularity, and advanced manufacturing.
ON gives university researchers access to a network of industry experts and investors, to help them refine and validate their ideas for commercial success, secure funding and build a company.
2024 marks the eighth edition of the three-month program, which will kick off in February. Two thirds of the teams involved include women cofounders.
CSIRO CEO, Doug Hilton said since its launch in 2015, ON alumni have formed 70 new companies, employed more than 600 people and raised more than $311 million in capital.
“ON Accelerate is about creating national benefits for Australia by giving researchers the skills they need to navigate their ideas along the often-fraught road between the lab and the market,” he said.
“Research commercialisation, science entrepreneurship and technical collaboration are all critical skills for Australia’s future and the ON program is equipping the next generation of innovators with the skills they need to make a difference for our future.”